UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13635) 13635
Book Chapter (30) 30
Magazine Article (28) 28
Newsletter (16) 16
Conference Proceeding (11) 11
Dissertation (6) 6
Book / eBook (3) 3
Government Document (3) 3
Web Resource (3) 3
Newspaper Article (2) 2
Publication (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9907) 9907
science & technology (6055) 6055
life sciences & biomedicine (5890) 5890
male (5839) 5839
female (5706) 5706
vinblastine - administration & dosage (5266) 5266
antineoplastic combined chemotherapy protocols - therapeutic use (4583) 4583
middle aged (4193) 4193
adult (4095) 4095
biological and medical sciences (3954) 3954
medical sciences (3484) 3484
oncology (3444) 3444
animals (3421) 3421
vinblastine - pharmacology (3396) 3396
aged (3339) 3339
vinblastine - analogs & derivatives (3308) 3308
vinblastine - therapeutic use (2870) 2870
chemotherapy (2491) 2491
pharmacology. drug treatments (2388) 2388
cisplatin - administration & dosage (2300) 2300
antineoplastic agents (2272) 2272
vinblastine (2255) 2255
vinblastine - adverse effects (1839) 1839
doxorubicin - administration & dosage (1677) 1677
antineoplastic combined chemotherapy protocols - adverse effects (1672) 1672
bleomycin - administration & dosage (1600) 1600
treatment outcome (1598) 1598
lung neoplasms - drug therapy (1556) 1556
hodgkin disease - drug therapy (1524) 1524
combined modality therapy (1343) 1343
adolescent (1340) 1340
mice (1288) 1288
neoplasm staging (1261) 1261
vinorelbine (1210) 1210
carcinoma, non-small-cell lung - drug therapy (1156) 1156
abridged index medicus (1097) 1097
antineoplastic combined chemotherapy protocols - administration & dosage (1039) 1039
cancer (971) 971
prognosis (952) 952
rats (943) 943
colchicine - pharmacology (928) 928
time factors (928) 928
antineoplastic agents - therapeutic use (921) 921
breast neoplasms - drug therapy (908) 908
drug administration schedule (894) 894
survival rate (866) 866
pharmacology & pharmacy (851) 851
vincristine - administration & dosage (835) 835
tumors (826) 826
methotrexate - administration & dosage (824) 824
deoxycytidine - analogs & derivatives (810) 810
dacarbazine - administration & dosage (799) 799
drug therapy, combination (779) 779
follow-up studies (768) 768
dose-response relationship, drug (766) 766
cyclophosphamide - administration & dosage (751) 751
survival analysis (730) 730
prednisone - administration & dosage (715) 715
disease-free survival (712) 712
aged, 80 and over (669) 669
lung neoplasms - pathology (667) 667
procarbazine - administration & dosage (663) 663
retrospective studies (653) 653
deoxycytidine - administration & dosage (642) 642
child (629) 629
remission induction (622) 622
neoplasm metastasis (614) 614
etoposide - administration & dosage (611) 611
microtubules - drug effects (593) 593
doxorubicin - therapeutic use (586) 586
hodgkin disease - radiotherapy (584) 584
antineoplastic agents - pharmacology (579) 579
bleomycin - therapeutic use (571) 571
antineoplastic agents - administration & dosage (562) 562
hodgkin disease - pathology (560) 560
hematology (559) 559
testicular neoplasms - drug therapy (556) 556
cisplatin - adverse effects (536) 536
cell line (531) 531
fundamental and applied biological sciences. psychology (527) 527
vinblastine - metabolism (527) 527
cisplatin - therapeutic use (523) 523
urinary bladder neoplasms - drug therapy (518) 518
carcinoma, non-small-cell lung - pathology (512) 512
drug resistance (507) 507
bleomycin - adverse effects (496) 496
cisplatin (495) 495
antineoplastic agents, phytogenic - therapeutic use (491) 491
antineoplastic agents, phytogenic - administration & dosage (490) 490
biochemistry & molecular biology (489) 489
cyclophosphamide - therapeutic use (489) 489
vincristine - therapeutic use (487) 487
antineoplastic agents, phytogenic - pharmacology (486) 486
kinetics (483) 483
tumor cells, cultured (483) 483
breast neoplasms - pathology (479) 479
paclitaxel - administration & dosage (466) 466
care and treatment (456) 456
research (456) 456
clinical trials as topic (453) 453
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12165) 12165
Japanese (532) 532
French (411) 411
German (317) 317
Russian (203) 203
Italian (140) 140
Chinese (126) 126
Spanish (102) 102
Polish (79) 79
Hungarian (20) 20
Dutch (15) 15
Czech (14) 14
Portuguese (13) 13
Hebrew (10) 10
Romanian (7) 7
Bulgarian (6) 6
Danish (5) 5
Serbian (5) 5
Korean (4) 4
Finnish (3) 3
Croatian (2) 2
Lithuanian (2) 2
Slovak (2) 2
Turkish (2) 2
Afrikaans (1) 1
Arabic (1) 1
Icelandic (1) 1
Norwegian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9796, pp. 1079 - 1088
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | General aspects | Medical sciences | Pneumology | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Vinblastine - administration & dosage | Carboplatin - adverse effects | Carcinoma, Squamous Cell - mortality | Vinblastine - analogs & derivatives | Antineoplastic Agents - adverse effects | Aged, 80 and over | Female | Paclitaxel - administration & dosage | Drug Administration Schedule | Deoxycytidine - administration & dosage | Carboplatin - administration & dosage | Paclitaxel - adverse effects | Survival Rate | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Clinical trials | Chemotherapy | Radiation therapy | Cancer therapies | Index Medicus | Abridged Index Medicus | Adenocarcinoma | Vinblastine | Carcinoma, Non-Small-Cell Lung | Antineoplastic Agents | Antineoplastic Combined Chemotherapy Protocols | Lung Neoplasms | Carcinoma, Squamous Cell | Life Sciences | Deoxycytidine | Paclitaxel | Carboplatin | Cancer
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9674, pp. 1525 - 1531
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | General aspects | Medical sciences | Pneumology | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptor, Epidermal Growth Factor - drug effects | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Young Adult | Antibodies, Monoclonal, Humanized | Vinblastine - analogs & derivatives | Aged, 80 and over | Adult | Female | Cetuximab | Carcinoma, Non-Small-Cell Lung - pathology | Proportional Hazards Models | Survival Rate | Treatment Outcome | Receptor, Epidermal Growth Factor - analysis | Carcinoma, Non-Small-Cell Lung - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Chemotherapy | Research | Comparative analysis | Lung cancer, Non-small cell | Drug therapy | Health aspects | Cancer | Drugs | Studies | Data analysis | Lung cancer | Acne | Monoclonal antibodies | Clinical medicine | Kinases | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2016, Volume 374, Issue 25, pp. 2419 - 2429
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 01/2011, Volume 29, Issue 3, pp. 264 - 271
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2018, Volume 378, Issue 4, pp. 331 - 344
Journal Article
9.